Department of Psychiatry, University of Oxford, Oxford, UK.
Mol Psychiatry. 2011 Sep;16(9):908-16. doi: 10.1038/mp.2010.90. Epub 2010 Sep 7.
The Apolipoprotein E (APOE) ɛ4 allele is the best-established genetic risk factor for sporadic Alzheimer's disease, and is also associated with structural gray matter and functional brain changes in healthy young, middle-aged and elderly subjects. Because APOE is implicated in brain mechanisms associated with white matter (WM) development and repair, we investigated the potential role played by the APOE polymorphism on WM structure in healthy younger (aged 20-35 years) and older (aged 50-78 years) adults using diffusion tensor imaging. General reduction of fractional anisotropy and increase in mean diffusivity values was found in carriers of the APOE ɛ4 allele relative to non-carriers. No significant interactions between genotype and age were observed, suggesting that differences in WM structure between APOE ɛ4-carriers and non-carriers do not undergo significant differential changes with age. This result was not explained by differences in brain morphology or cognitive measures. The APOE ɛ4 allele modulates brain WM structure before any clinical or neurophysiological expression of impending disease.
载脂蛋白 E (APOE) ε4 等位基因是散发性阿尔茨海默病最明确的遗传风险因素,也与健康的年轻、中年和老年受试者的结构性灰质和功能性大脑变化有关。由于 APOE 与与白质 (WM) 发育和修复相关的大脑机制有关,我们使用弥散张量成像研究了 APOE 多态性对健康年轻(20-35 岁)和老年(50-78 岁)成年人 WM 结构的潜在作用。与非携带者相比,APOE ε4 携带者的各向异性分数和平均弥散度值普遍降低。未观察到基因型与年龄之间的显著相互作用,这表明 APOE ε4 携带者和非携带者之间的 WM 结构差异不会随着年龄的增长而发生显著变化。这一结果不能用脑形态或认知测量的差异来解释。APOE ε4 等位基因在疾病即将出现的任何临床或神经生理学表现之前调节大脑 WM 结构。